Insulin Resistance Markers to Detect Nonalcoholic Fatty Liver Disease in a Male Hispanic Population

Table 2

Association between insulin resistance markers (HOMA-IR, TyG, and TG/HDL) and nonalcoholic fatty liver disease (NAFLD).

IR markers	Model 1^§			Model 2
	OR	IC 95%	value	OR	IC 95%	value
HOMA-IR
T1 (0.24–1.23)	Ref.
T2 (1.24–1.94)	2.26	0.93–5.87	0.079	1.79	0.66–5.15	0.262
T3 (1.95–9.24)	10.32	4.69–25.42	<0.001	4.08	1.58–11.34	0.004
TyG index
T1 (7.21–8.58)	Ref.
T2 (8.59–9.08)	4.17	1.76–11.09	0.002	3.17	1.18–9.42	0.020
T3 (9.09–10.87)	9.14	4.01–23.74	<0.001	4.07	1.54–11.88	0.003
TG/HDL ratio
T1 (0.48–2.57)	Ref.
T2 (2.58–4.44)	3.41	1.42–9.15	0.008	1.69	0.60–5.12	0.331
T3 (4.45–32.1)	10.92	4.79–28.39	<0.001	4.05	1.53–11.80	0.007

IR, insulin resistance; HOMA-IR, the homeostasis model assessment index; TyG, triglycerides/glucose; TG/HDL, triglycerides/high-density lipoprotein. ^§Unadjusted model. Adjusted model for age, BMI, waist circumference, hip circumference, visceral, and subcutaneous fat.